These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 154749)

  • 1. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].
    Mutoh S; Teh A; Shimoji Y; Nishi N; Saitoh M; Maki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2049-58. PubMed ID: 3878385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The coagulation and fibrinolysis activities of the blood during various phases of labor].
    Schander K; Wahl W; Rehm A
    Fortschr Med; 1979 Oct; 97(38):1696-702. PubMed ID: 92443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric.
    Aylward M
    Postgrad Med J; 1978; 54 Suppl 2():31-7. PubMed ID: 740578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
    Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
    Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.
    Notelovitz M; Kitchens C; Ware M; Hirschberg K; Coone L
    Obstet Gynecol; 1983 Nov; 62(5):596-600. PubMed ID: 6621949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation changes following hepatic revascularization during liver transplantation.
    Harper PL; Luddington RJ; Jennings I; Reardon D; Seaman MJ; Carrell RW; Klink JR; Smith M; Rolles K; Calne R
    Transplantation; 1989 Oct; 48(4):603-7. PubMed ID: 2529679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators.
    Raasveld MH; Hack CE; ten Berge IJ
    Thromb Haemost; 1992 Sep; 68(3):264-7. PubMed ID: 1279831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection.
    Shimada M; Matsumata T; Shirabe K; Kamakura T; Taketomi A; Sugimachi K
    J Am Coll Surg; 1994 May; 178(5):498-502. PubMed ID: 8167888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation studies of menopausal women taking estrogen replacement.
    Beller FK; Nachtigall L; Rosenberg M
    Obstet Gynecol; 1972 May; 39(5):775-8. PubMed ID: 4260072
    [No Abstract]   [Full Text] [Related]  

  • 20. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.